This opportunity is no longer accepting applications.
grant RFA-AI-24-057
Strategies for Eliminating HIV Proteins (R01 Clinical Trial Not Allowed)
This grant opportunity aims to fund projects focused on creating molecules that can either break down HIV proteins or RNA, or block the conversion of HIV RNA into proteins. The goal is to tackle HIV proteins that traditional drug methods struggle to target.
This purpose of this notice of funding opportunity (NOFO) is to support the development of molecules that target HIV proteins or RNA for degradation or that interfere with the translation of HIV RNA into protein. This approach has the potential of eliminating HIV proteins that have been difficul…
Funding Source
Agency: National Institutes of Health
Sub-agency: National Institute of Allergy and Infectious Diseases
Program: SBIR
Dates
Opportunity Released: August 29, 2024
Open for Submission: August 29, 2024
Submission Deadline: December 4, 2024
Application Window Closes: December 4, 2024
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers